The next Age-Friendly Health System Action Community will commence March 25 and run through October, offering free monthly webinars and an in-person meeting to help hospitals and health systems integrate “age-friendly” health care. Participants will learn to use the 4Ms Framework — an evidence-based model focused on what matters, medications, mentation and mobility —  to support the needs of aging communities in clinical settings. For more on Age-Friendly Health Systems, an initiative of the John A. Hartford Foundation and Institute for Healthcare Improvement in partnership with the AHA and Catholic Health Association of the United States, click here

The John A. Hartford Foundation also is providing scholarships for a cohort of Age-Friendly Fellows who will participate in AHA’s Next Generation Leaders Fellowship. The deadline to apply is Feb. 28. Scholarship recipients will implement the 4Ms Framework at their organization for their change project in the fellowship program. 

Related News Articles

Chairperson's File
Public
For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
Headline
The National Emerging Special Pathogens Training and Education Center announced Oct. 15 that it will award $37.5 million in grants to 75 hospitals seeking to…
Chairperson's File
Public
There is a saying that is very timely for our field: A smooth sea never made a skilled sailor. As we head into the final months of 2025, hospitals and health…
Headline
The AHA’s American Society for Healthcare Risk Management will host the ASHRM25 Virtual Conference Nov. 5-7. This event, designed for health care leaders in…
Chairperson's File
Public
Although hospitals and health systems are facing many pressures and challenges, now is the time to truly transform how we care for our patients and communities…
Chairperson's File
Public
With all of the challenges facing health care — a shrinking workforce population, reduced funding, new technologies and pharmaceuticals — it's no longer an…